With this recognition, SMO India becomes one of a select group of organisations globally authorised under the FDA’s Third-Party Review Program...
The P-Cure centre is the first and only facility in the world to routinely deliver proton therapy to patients using its upright technology...
CE Mark certification enables commercialisation across Europe and other CE-recognising markets...
The approval comes following the results from The Squid Trial for the Embolisation of the Middle meningeal artery (STEM) for the treatment of chronic Sub-Dural Hematoma study...
A newly developed AI control system using neuron-inspired learning enables soft robotic arms to learn a broad set of motions once and adapt instantly to changing conditions without retraining...
The IND clearance enables Trace to initiate first-in-human clinical studies evaluating the safety and intraoperative performance of LGW16-03 in surgical settings...
The JADA System for treatment of abnormal postpartum uterine bleeding, and the team behind the product, join Laborie, strengthening the company's commitment to improving maternal health...
Polarean’s Xenon MRI platform is opening a new window into the pulmonary microvasculature, long considered a “silent zone” in cardiopulmonary disease and reshaping how pharma sponsors evaluate therapeutic response...
Researchers develop an innovative dural patch that achieves rapid, watertight sealing of dural tears, boasting high biocompatibility...
Artificial intelligence simplifies patient workflow, improves image quality, and accelerates exams...
